Distribuzione geografica
Continente #
NA - Nord America 14809
EU - Europa 1611
AS - Asia 1105
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 7
OC - Oceania 5
AF - Africa 2
Totale 17548
Nazione #
US - Stati Uniti d'America 14789
CN - Cina 704
IT - Italia 438
VN - Vietnam 345
SE - Svezia 291
FI - Finlandia 289
DE - Germania 213
UA - Ucraina 163
GB - Regno Unito 114
IE - Irlanda 42
IN - India 29
FR - Francia 23
NL - Olanda 17
CA - Canada 13
EU - Europa 8
IL - Israele 8
BZ - Belize 7
BE - Belgio 6
PE - Perù 5
PL - Polonia 5
JP - Giappone 4
TR - Turchia 4
HK - Hong Kong 3
NZ - Nuova Zelanda 3
RO - Romania 3
AU - Australia 2
CH - Svizzera 2
NO - Norvegia 2
PH - Filippine 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
HR - Croazia 1
IQ - Iraq 1
IR - Iran 1
MA - Marocco 1
NG - Nigeria 1
RU - Federazione Russa 1
Totale 17548
Città #
Fairfield 2700
Woodbridge 1652
Chandler 1395
Houston 1246
Ann Arbor 1100
Ashburn 1013
Cambridge 994
Seattle 957
Wilmington 867
Jacksonville 701
Princeton 374
Dong Ket 344
San Diego 270
Padova 223
Beijing 217
Medford 216
Des Moines 182
Roxbury 157
Nanjing 135
Helsinki 117
Boardman 107
Shenyang 43
Dublin 39
Nanchang 38
Hebei 35
Norwalk 34
Falls Church 30
Guangzhou 30
Jinan 26
Jiaxing 25
Redwood City 25
Changsha 24
London 23
Tianjin 19
Dearborn 18
Zhengzhou 17
Hefei 15
San Jose 13
Kunming 12
Borås 10
Kharkiv 10
Nürnberg 10
Florence 8
Haikou 8
Indiana 8
Milan 8
Belize City 7
Chicago 7
Rome 7
Hangzhou 6
Ningbo 6
Brussels 5
Ramat Gan 5
Renton 5
Rockville 5
San Francisco 5
Albuquerque 4
Catania 4
Istanbul 4
Las Vegas 4
Lima 4
Munich 4
Naples 4
Redmond 4
Taiyuan 4
Turin 4
Villavesco 4
Auburn Hills 3
Brendola 3
Dallas 3
Detroit 3
Herzliya 3
Lanzhou 3
Legnaro 3
Ottawa 3
Phoenix 3
Pisa 3
Saint Louis 3
Shanghai 3
Xian 3
Anguillara Veneta 2
Berlin 2
Buffalo 2
Carmignano Di Brenta 2
Castelbello 2
Chengdu 2
Chongqing 2
Columbus 2
Como 2
Easton 2
Frankfurt am Main 2
Fuzhou 2
Gastonia 2
Geislingen an der Steige 2
Groningen 2
Limbiate 2
Los Angeles 2
Menlo Park 2
New York 2
North York 2
Totale 15676
Nome #
A 10-year history of secondary hypertension: A challenging case of renin-secreting juxtaglomerular cell tumor 153
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155) 150
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 147
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients 142
Diagnosis and complications of Cushing's disease: gender-related differences. 140
Unilateral adrenal tumor, erectile dysfunction and infertility in a patient with 21-hydroxylase deficiency: effects of glucocorticoid treatment and surgery 133
Activation of the dopamine receptor type-2 (DRD2) promoter by 9-cis retinoic acid in a cellular model of Cushing's disease mediates the inhibition of cell proliferation and ACTH secretion without a complete corticotroph-to-melanotroph transdifferentiation 129
Age and the metabolic syndrome affect salivary cortisol rhythm: Data from a community sample 129
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas 126
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor 126
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC 125
First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS 123
The Role of Unilateral Adrenalectomy in ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH). 119
Crude extract of Origanum vulgare L. induced cell death and suppressed MAPK and PI3/Akt signaling pathways in SW13 and H295R cell lines 119
Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center. 118
Perioperative multidisciplinary management of endoscopic transsphenoidal surgery for sellar lesions: practical suggestions from the Padova model 118
Herniation of cerebellar tonsils in acromegaly: prevalence, pathogenesis and clinical impact. 117
Screening tests for cushing's syndrome: Urinary free cortisol role measured by LC-MS/MS 115
New insight into the Hypercoagulability of Cushing's Syndrome 114
An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experience. 114
Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing’s disease 114
A venous thromboembolism risk assessment model for patients with Cushing’s syndrome 113
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up 113
Aldosterone in Gynecology and Its Involvement on the Risk of Hypertension in Pregnancy 111
A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma 110
Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up. 106
Intracranial internal carotid artery changes in acromegaly: a quantitative magnetic resonance angiography study. 106
The medical treatment with pasireotide in Cushing's disease: an Italian multicentre experience based on "real-world evidence" 106
Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate 105
Analysis of gpr101 and aip genes mutations in acromegaly: a multicentric study. 105
Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas 105
A scoring system increases specificity of I-MIBG scan for the diagnosis of pheochromocytoma 104
HLA and hormonal studies in 5 patients with late-onset 21-hydroxylase deficiency syndrome (21OHDS). 104
Improved salivary cortisol rhythm with dual-release hydrocortisone 104
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 104
Treatment of polycystic ovary syndrome with spironolactone plus licorice. 101
Combination therapy for Cushing's disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole? 100
Metyrapone treatment in Cushing’s syndrome: a real-life study 100
Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. 98
Early recognition of aggressive pituitary adenomas: a single-centre experience 98
Diagnostic performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma and adrenal insufficiency. 98
Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency 98
Food-dependent Cushing's syndrome: from molecular characterization to therapeutical results 97
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group. 96
Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth? 96
The diagnostic performance of urinary free cortisol is better than the cortisol:cortisone ratio in detecting de novo Cushing's syndrome: the use of a LC-MS/MS method in routine clinical practice 96
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 96
Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation 96
Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia. 95
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 94
Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome 93
Medical Treatment for Acromegaly does not Increase the Risk of Central Adrenal Insufficiency: A Long-Term Follow-Up Study 93
Gonadotropin secreting pituitary adenoma associated with erythrocytosis: case report and literature review. 92
Adrenal nodules in patients with Cushing's disease: prevalence, clinical significance and follow-up. 92
Conventional and nuclear medicine imaging in Ectopic Cushing's syndrome: A systematic review 92
Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury 91
Efficacy and safety of high-dose long-acting repeatable octreotide as monotherapy or in combination with pegvisomant or cabergoline in patients with acromegaly not adequately controlled by conventional regimens: results of an open-label, multicentre study 91
Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly 90
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line 90
Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome 90
Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study 89
The effects of iodine supplementation in pregnancy on iodine status, thyroglobulin levels and thyroid function parameters: Results from a randomized controlled clinical trial in a mild-to-moderate iodine deficiency area 89
Hypercortisolism and pregnancy upregulate von Willebrand factor through different mechanisms: report on a pregnant patient with Cushing's syndrome. 89
Furosemide and 11beta-hydroxysteroid dehydrogenase activity, in man. 88
Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. 88
Investigation of N-cadherin/β-catenin expression in adrenocortical tumors 88
PTH: Redefining Reference Ranges in a Healthy Population-The Role of Interfering Factors and the Type of Laboratory Assay 88
Increased rate of intracranial saccular aneurysms in acromegaly: an MR angiography study and review of the literature. 88
Therapeutic strategies for Cushing's syndrome: An update 87
Different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia 87
Unilateral adrenal tumor, erectile dysfunction and infertility in a patient with 21-hydroxylase deficiency: effects of glucocorticoid treatment 86
Potential Role for Retinoic Acid in Patients with Cushing's Disease. 86
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 86
The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome 86
Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma 85
New insights to the potential mechanisms driving coronary flow reserve impairment in Cushing's syndrome: A pilot noninvasive study by transthoracic Doppler echocardiography 85
A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype 84
Steroids and Hypertension 84
The body fat mass and extracellular water changes: effect of licorice in human 83
The R304X mutation of the Aryl hydrocarbon receptor Interacting Protein gene in familial isolated pituitary adenomas: mutational Hot-Spot or founder effect? 83
Inhibitory effect of somatostatin on the aldosterone response to angiotensin II: in vitro studies. 83
Retinal abnormalities associated with a mutation of the nucleotide 683 in von Hippel-Lindau disease 83
Secondary Arterial Hypertension: From Routine Clinical Practice to Evidence in Patients with Adrenal Tumor 83
The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging 82
Acromegaly is associated with increased cancer risk: a survey in Italy 81
Risk factors and long-term follow-up of adrenal incidentalomas 80
The glucose-dependent insulinotropic polypeptide receptor (GIPR) is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives GH-promoter activity in GH3 cells. 80
Glucose metabolism abnormalities in Cushing's syndrome: from molecular basis to clinical management 80
Predicting late recurrence in surgically-treated patients with Cushing's disease. 80
The M235T polymorphism of the angiotensinogen gene in women with polycystic ovary syndrome 79
Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry 79
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS) 79
Cost-effective therapy in patients with idiopathic hirsutism. 78
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH dependent Cushing's syndrome 78
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 78
Growth hormone and insulin-like growth factor I in a Sydney Olympic gold medallist 77
No linkage between HLA and congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency. 77
Venous thromboembolism in patients with Cushing's syndrome: need of a careful investigation of the prothrombotic risk profile. 77
Totale 9934
Categoria #
all - tutte 33211
article - articoli 30926
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 349
Totale 64486

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018166 0000 00 00 8101471
2018/20191684 32116714 308 18139 20254540470
2019/20204191 45414864408 419286 404458 546442335227
2020/20213441 191247203229 112183 139275 456353393660
2021/20223801 130401426278 251248 185424 18498350826
2022/20232602 63135737342 401353 16192 273000
Totale 17932